Articles

Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients

Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan;Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
Laboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, University of Tokyo, Tokyo Japan
Medical Genetics Laboratory, Graduate School of Science and Engineering, Kindai University, Osaka, Japan
Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan
Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan
Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan;Department of Applied Information Sciences, Graduate School of Information Sciences, Tohoku University, Sendai, Japan;Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan
Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
Department of Pediatrics, Japanese Red Cross Narita Hospital, Chiba, Japan
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
Department of Pediatrics and Adolescence, Sapporo Hokuyu Hospital, Sapporo, Japan
Department of Hematology and Immunology, Kanazawa Medical University, Uchinada-machi, Japan
Department of Community Pediatrics, Perinatal and Maternal Medicine, Tokyo Medical and Dental University, Tokyo, Japan
Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan
Medical Genetics Laboratory, Graduate School of Science and Engineering, Kindai University, Osaka, Japan
Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan;Department of Medical Biochemistry, Graduate School of Medicine, Tohoku University, Sendai, Japan
Laboratory of DNA Information Analysis, Human Genome Center, The Institute of Medical Science, University of Tokyo, Tokyo Japan
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan;Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden
Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan
Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan
Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan
Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
Vol. 104 No. 10 (2019): October, 2019 https://doi.org/10.3324/haematol.2018.207241